
生物谷 — Investor Relations & Filings
Bio-Valley specializes in the research, development, and manufacturing of botanical-based therapeutic solutions, with a primary focus on cardiovascular and cerebrovascular health. The company is a leader in the industrialization of Erigeron breviscapus (Dengzhanhua), a botanical resource used for treating ischemic stroke and its sequelae. Its core product portfolio includes Dengzhan Shengmai Capsules and Dengzhan Xixin Injection, which are utilized in clinical settings for their neuroprotective and microcirculation-improving properties. Bio-Valley maintains a comprehensive value chain encompassing botanical cultivation, standardized extraction, and large-scale production. By leveraging advanced extraction technologies and rigorous quality control, the company provides evidence-based solutions for chronic disease management and geriatric care.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 第五届监事会第六次会议决议公告 | 2025-09-10 | Chinese | |
| 网络投票实施细则 | 2025-09-10 | Chinese | |
| 董事会议事规则 | 2025-09-10 | Chinese | |
| 独立董事专门会议工作制度 | 2025-09-10 | Chinese | |
| 承诺管理制度 | 2025-09-10 | Chinese | |
| 投资者关系管理制度 | 2025-09-10 | Chinese |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 39806731 | 第五届监事会第六次会议决议公告 | 2025-09-10 | Chinese | ||
| 39806723 | 网络投票实施细则 | 2025-09-10 | Chinese | ||
| 39806711 | 董事会议事规则 | 2025-09-10 | Chinese | ||
| 39806701 | 独立董事专门会议工作制度 | 2025-09-10 | Chinese | ||
| 39806693 | 承诺管理制度 | 2025-09-10 | Chinese | ||
| 39806683 | 投资者关系管理制度 | 2025-09-10 | Chinese | ||
| 39806677 | 董事会提名委员会工作细则 | 2025-09-10 | Chinese | ||
| 39806671 | 总经理工作细则 | 2025-09-10 | Chinese | ||
| 39806661 | 内部审计制度 | 2025-09-10 | Chinese | ||
| 39806654 | 子公司管理制度 | 2025-09-10 | Chinese | ||
| 39806649 | 合同管理制度 | 2025-09-10 | Chinese | ||
| 39806640 | 关联交易管理制度 | 2025-09-10 | Chinese | ||
| 39806636 | 信息披露事务管理制度 | 2025-09-10 | Chinese | ||
| 39806630 | 董事离任公告 | 2025-08-31 | Chinese | ||
| 39806623 | 国新证券股份有限公司关于云南生物谷药业股份有限公司2025年半年度持续督导跟踪报告 | 2025-08-31 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
生物谷 via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58793/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58793 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58793 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58793 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58793}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for 生物谷 (id: 58793)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.